Skip to main content
Log in

Betting Swiss gold on HPV vaccination

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Szucs TD, Largeron N, Dedes KJ, Rafia R, Bénard S.Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Current Medical Research and Opinion 24: 1473-1483, No. 5, 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Betting Swiss gold on HPV vaccination. Pharmacoecon. Outcomes News 554, 7 (2008). https://doi.org/10.2165/00151234-200805540-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805540-00015

Keywords

Navigation